Science Applications International Corporation (NASDAQ:SAIC ) Q1 2026 Earnings Conference Call June 2, 2025 10:00 AM ET Company Participants Joseph DeNardi - Senior Vice President, Investor Relations and Treasurer Toni Townes-Whitley - Chief Executive Officer Prabu Natarajan - Executive Vice President and Chief Financial Officer Conference Call Participants Gavin Parsons - UBS Gautam Khanna - TD Cowen Jason Gursky - Citi Sheila Kahyaoglu - Jefferies Tobey Sommer - Truist Colin Canfield - Cantor Fitzgerald Noah Poponak - Goldman Sachs Operator Good day and thank you for standby. Welcome to the SAIC Fiscal Year 2026 Quarter One Earnings Conference Call.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

GCM Grosvenor shares have outperformed the S&P 500, delivering a 73% total return over the past three years. Recent Q1 earnings were strong, and several near-term growth drivers are in place for continued earnings momentum. The stock trades at a significant valuation discount to both the broader market and its peers, despite superior growth prospects.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cable One, Inc. (“Cable One” or the “Company”) (NYSE: CABO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Evo Series Expands with Options for Increased Material and Color Expression and User Comfort Evo Series Expands with Options for Increased Material and Color Expression and User Comfort

Study Aims to Expedite Potentially Transformative Therapies By Assessing Safety and Efficacy of FSD202 Study Aims to Expedite Potentially Transformative Therapies By Assessing Safety and Efficacy of FSD202

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Metallus Inc. (“Metallus” or the “Company”) (NYSE: MTUS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

Intuit (INTU) possesses solid growth attributes, which could help it handily outperform the market.

Palomar (PLMR) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Fortuna (FSM) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Jakks (JAKK) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Red Violet (RDVT) could produce exceptional returns because of its solid growth attributes.

CareTrust REIT (CTRE) possesses solid growth attributes, which could help it handily outperform the market.

Broadcom Inc. (AVGO) possesses solid growth attributes, which could help it handily outperform the market.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Biohaven Ltd. ("Biohaven Ltd.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=151313&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=151317&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Photronics, Inc. ("Photronics, Inc.") (NASDAQ:PLAB) concerning possible violations of federal securities laws. Photronics issued a press release on May 28, 2025, reporting its financial results for the second quarter of 2025.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tempus AI, Inc. ("Tempus AI, Inc.") (NASDAQ:TEM) concerning possible violations of federal securities laws. Spruce Point Capital Management ("Spruce Point") published a report on Tempus, on May 28, 2025, describing a number of "concerns" about the Company.